Skip to main content
NIBEC CO., LTD. logo

NIBEC CO., LTD. — Investor Relations & Filings

Ticker · 138610 ISIN · KR7138610001 KO Manufacturing
Open in API
Filings indexed 218 across all filing types
Latest filing 2026-05-18 Investor Presentation
Country KR South Korea
Listing KO 138610

About NIBEC CO., LTD.

https://nibec.co.kr/en/

NIBEC CO., LTD. is a biotechnology company specializing in the research, development, and commercialization of healthcare solutions centered on proprietary peptide technology. The company's core activities involve the manufacturing of tissue regenerative biomaterials, such as dental bone grafts and collagen-based products, as well as biomaterial-based medical devices. In addition to its focus on regenerative medicine, NIBEC develops and markets a range of dental care and cosmetic products. The company is also actively engaged in the research and development of novel peptide-based drugs and bio-fusion technologies to address various therapeutic needs.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Investor Presentation Classification · 80% confidence The document is an announcement of an upcoming investor relations meeting (기업설명회/IR), detailing the date, time, venue, participants, agenda, sponsor, and where IR materials will be posted. It is not the actual financial report or presentation content but an IR event notice. The closest match in our taxonomy is Investor Presentation (IP), which covers presentations and materials for investors.
2026-05-18 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 92% confidence The document is titled “분기보고서” covering the period 2026.01.01 to 2026.03.31 (1Q), contains detailed financial tables, company overview, business description, capital changes, and other substantive interim financial and operational data. This is the full interim/quarterly report itself, not merely an announcement. Therefore, it falls under the Interim / Quarterly Report category. Q1 2026
2026-05-14 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 85% confidence The document is a formal report filed with the Financial Services Commission/Korea Exchange describing the grant of stock options (주식매수선택권 부여) including terms, exercise conditions, and number of shares. It is not a full annual or quarterly report, nor an earnings release or management change. It specifically announces a capital change through the issuance of new shares upon exercise of options. This best matches the Share Issue/Capital Change category (SHA).
2026-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is the official report of the company’s annual general meeting held on 2026-03-30, listing each agenda item, voting results (percentages, approval status), and related shareholder resolutions. It does not contain the full annual report or financial statements text itself, nor is it an investor presentation or management discussion. Rather, it provides the detailed voting results of AGM agenda items, which aligns exactly with the 'Declaration of Voting Results & Voting Rights Announcements' definition.
2026-03-30 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 95% confidence The document is a comprehensive financial report titled '감사보고서' (Audit Report) for the company '주식회사 나이벡' (NIBEC Co., Ltd.). It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes (주석) for the fiscal year ending December 31, 2025. While it contains an audit report, the document is a full set of audited financial statements, which is the primary component of an Annual Report (10-K equivalent in the Korean context). FY 2025
2026-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is a regulatory filing from the Korean stock exchange (KRX) system titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of the audit opinion, key financial data, and auditor information for the fiscal year 2025. While it contains financial data, it is a standardized regulatory disclosure form announcing the receipt and submission of the audit report rather than the full, multi-page audit report document itself. Therefore, it falls under the category of a regulatory filing. FY 2025
2026-03-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.